Seema Patil, MD
Gastroenterology · Laurel, MDNPI 1285816173
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 69.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $5,456 and has fallen 77.5% since, to $1,225 in 2025.
Across 149 payments — averaging $62.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$6K
- Takeda Pharmaceuticals U.S.A., Inc.$768
- AbbVie$597
- Bristol Myers Squibb$420
- Pfizer$319
- Madrigal Pharmaceuticals$171
- plus $591 from 15 others
Across 8 payments — averaging $5725.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB Biosciences Inc.$22K
- Takeda Pharmaceuticals U.S.A., Inc.$20K
- Janssen Research & Development, LLC$4K
What the payments were for
- Consulting fees$4,17045%
- Travel & lodging$491%
- Food & beverage$5,04754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 50 | $6,399 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $768 |
| AbbVie | 19 | $597 |
| Bristol Myers Squibb | 15 | $420 |
| Pfizer | 15 | $319 |
| Madrigal Pharmaceuticals | 3 | $171 |
| Medtronic | 1 | $146 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $82 |
| Lilly USA, LLC | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| Sanofi | 1 | $37 |
| Janssen Scientific Affairs, LLC | 1 | $34 |
| Amgen | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Celltrion USA Inc. | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Shionogi Inc | 1 | $21 |
| Organon | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Sandoz | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,266 in reported general payments places this provider in the 80th percentile of 455 gastroenterology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 29 | $1,407,290 |
| LoperamideLoperamide Hcl | 31 | $3,164 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 34 | $2,167 |
| Opium Tincture | 14 | $2,037 |
| Lansoprazole | 11 | $1,819 |
| Ondansetron OdtOndansetron | 11 | $469 |
| Dicyclomine Hcl | 12 | $389 |
| Prednisone | 17 | $174 |
| Omeprazole | 19 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $768 | $1,407,29029 claims |
| SandozLansoprazole | $17 | $1,81911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 455 gastroenterology providers in Maryland.
Other gastroenterology in Laurel
- Darryn PotoskyLaurel$72K
- Theodore KimLaurel$20K
- Apurva ModiRockville$1.1M
- Sergey KantsevoyBaltimore$1.1M
- Anurag MaheshwariBaltimore$803K
- Aline Charabaty PishvaianBaltimore$631K
- Zachary BormanChevy Chase$520K
- Mouen KhashabBaltimore$440K
- Erica CohenChevy Chase$385K
- Natarajan RavendhranCatonsville$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.